Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy

RT @ElizSMcKenna: Wow, "Y220C mutation is the ninth most frequent p53 missense mutant overall and is associated with over 100,000 new cance…

Wow, "Y220C mutation is the ninth most frequent p53 missense mutant overall and is associated with over 100,000 new cancer cases per year worldwide" (ref: https://t.co/wmStipLJla)

New research: Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy: The transcription factor p53 is a key tumor suppressor that is inactivated in almost all cancers due to either point mutations in the TP53 gene or… https://t.co